Adenovirus Diagnostic Market is Set to Record Exponential Growth by 2019

Adenoviruses are major causes of febrile illness among children. They can infect the membranes of respiratory tract, intestines, eyes and urinary tract causing pharyngitis, pneumonia and gastroenteritis, bronchiolitis, hemorrhagic cystitis and conjunctivitis. There are 57 types of adenoviruses known to infect human beings, classified into seven categories from A to G on the basis of genome size and composition. Human Adenovirus A, B and C cause respiratory infection while HAdV B & D cause conjunctivitis. Children are more susceptible to adenovirus infections than adults and aging population.

Late winter, early summer and spring are the most common time for this infection to occur. Adenoviruses are one of the major causes of respiratory infections among children and cause of diarrhea. As these infections are not specific, so they cannot be diagnosed on the basis of clinical symptoms only. A number of diagnostic methods used to confirm the presence of adenovirus infection include viral culture, polymerase chain reaction assays and antigen based assays. Others emerging technologies such as monoclonal antibodies, liposomes, flow cytometry, chromatography and gel microdroplets are of vital use in diagnosis of adenovirus infection.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1456

The diagnostic tests for adenovirus infections are generally conducted at hospitals, private diagnostic laboratories, small clinics and public health laboratories. A study conducted by Barcelona Center for International Health Research and University of Bacelona on children suffering from pneumonia suggests that adenovirus is the second most respiratory virus causing pneumonia. Although the Adenovirus Diagnostics Market is considered to be mature, it may grow in emerging markets where a large number of children infected with adenovirus are under served. Geographically, North America represents the largest market as hospitals and private diagnostics laboratories in United States and Canada offer a broad portfolio of tests to determine the presence of adenovirus and due to reimbursement policy covering adenovirus diagnostics.

Some of the key players operating in this market are Affymetrix, Becton Dickinson, Roche, Bio-Rad, Gen-Probe, Novartis AG, Qiagen, Diasorin, Abbott and bioMerieux.

View Report -

https://www.transparencymarketresearch.com/adenovirus-diagnostic-market.html

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.